Mycophenolic acid and Septra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolic acid (mycophenolic acid) and Septra (sulfamethoxazole; trimethoprim). Common drug interactions include sputum discoloured among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolic acid and Septra. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolic acid?

Mycophenolic acid has active ingredients of mycophenolic acid. eHealthMe is studying from 16,233 Mycophenolic acid users. Check the latest studies of Mycophenolic acid.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.



On Jul, 04, 2026

34 people who take Mycophenolic acid and Septra together, and have interactions are studied.

Mycophenolic acid and Septra drug interactions.

What are the common drug interactions of Mycophenolic Acid and Septra, by gender? *:

female:

  1. Sputum discoloured
  2. Synovitis (inflammation of the synovial membrane)
  3. Peripheral swelling
  4. Asthma
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Autoimmune hepatitis
  7. C-reactive protein increased
  8. Cough
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

male:

  1. Diarrhoea
  2. Blood creatinine increased
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Diabetic nephropathy (diabetic kidney disease)
  5. Nausea (feeling of having an urge to vomit)
  6. Nephropathy toxic (damage to kidney due to toxins)
  7. Peroneal nerve palsy
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Sciatic nerve neuropathy (sciatic nerve damage)
  10. Transaminases increased

What are the common drug interactions of Mycophenolic Acid and Septra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood bicarbonate decreased
  2. Blood chloride increased
  3. Blood creatinine increased
  4. Blood glucose increased
  5. Diarrhoea
  6. Haemoglobin decreased
  7. Leukocytosis (increased white blood cells)
  8. Lymphocyte count decreased
  9. Pyrexia (fever)

20-29:

n/a

30-39:

  1. Blood creatinine increased
  2. Fatigue (feeling of tiredness)
  3. Haemoglobin decreased
  4. Haemorrhage (bleeding)
  5. Headache (pain in head)
  6. Hypertension (high blood pressure)
  7. Induced labour (prematurely stimulating childbirth in a woman)
  8. Infusion site pain
  9. Nausea (feeling of having an urge to vomit)
  10. Obstructive airways disorder (a progressive disease that makes it hard to breathe)

40-49:

  1. Sputum discoloured
  2. Vomiting
  3. Abdominal distension
  4. Abdominal pain
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  6. Arthralgia (joint pain)
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  8. Asthenia (weakness)
  9. Bile duct stenosis (abnormal narrowing of the common bile duct)
  10. Blood creatinine increased

50-59:

  1. Anaemia (lack of blood)
  2. Infusion related reaction
  3. Peroneal nerve palsy
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Sciatic nerve neuropathy (sciatic nerve damage)
  6. Transaminases increased
  7. Allergy to chemicals
  8. Ankle fracture
  9. Biliary tract disorder
  10. Cardiac disorder

60+:

  1. Drug ineffective
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Back pain
  4. Bk virus infection
  5. Bladder spasm
  6. Bone erosion
  7. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  8. Cholecystitis (infection of gallbladder)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 14.71%
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 5.88%
  3. Pain: 2 people, 5.88%
  4. Myositis (inflammation of the muscles): 2 people, 5.88%
  5. Immunodeficiency Disorders: 2 people, 5.88%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%
  7. Blood Sodium Abnormal: 2 people, 5.88%
  8. Asthma: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolic acid and Septra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mycophenolic acid and Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycophenolic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Septra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolic acid and sulfamethoxazole; trimethoprim (the active ingredients of Mycophenolic acid and Septra, respectively), and Mycophenolic acid and Septra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: